Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, has introduced a new gamma detection probe at the American College of Surgeons 92^nd Annual Clinical Congress meeting in Chicago. The new probe uses Bluetooth wireless technology to communicate gamma radiation counts to the company’s neo2000 control unit.

The wireless probe eliminates cumbersome cables that can complicate the surgical field and provides the surgeon with operative field flexibility. The probe is designed to be used with all existing models of the company’s neo2000 system (models 2000, 2100 and 2200). The wireless probe will be available with either a straight or angled detection tip. The neo2000 line of gamma detection systems are used by cancer surgeons in a procedure called sentinel lymph node biopsy (SLNB) or intraoperative lymphatic mapping (ILM).

The first commercial shipments of the probe are slated to occur during the fourth quarter of 2006.